目录
- Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)
- Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
- Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
- Psychosomatic symptoms affect radiotherapy setup errors in early breast cancer patients
- Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma
- Pain threshold,anxiety and other factors affect intensity of postoperative pain in gastric cancer patients:A prospective cohort study
- A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
- Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns
- Prognostic value of a modified Immunoscore in patients with stage I-III resectable colon cancer
- Single-cell DNA methylome analysis of circulating tumor cells
- Phase 1 studies comparing safety,tolerability,pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphoma
- Current evidence and challenges of systematic therapies for adult recurrent glioblastoma:Results from clinical trials